Veterinary Medicine Erythromycin Ethylsuccinate Powder CAS 1264-62-6 Raw Materials

CAS: 1264-62-6

MF: C43H75NO16

MW: 862.05

EINECS:  215-033-8

Specification​: 99% min Erythromycin Ethylsuccinate

Sample: Erythromycin Ethylsuccinate Powder

Packaging:1kg/bag, 25kg/drum

Brand: Henrikang

Appearance: White Powder

Storage: Cool Dry Place

Shelf Life: 2 Years

Test Method: HPLC

Portal:https://henrikang.en.made-in-china.com/

Erythromycin Ethylsuccinate Powder Usage and Synthesis.

Erythromycin Ethylsuccinate is an oral macrolide antimicrobial agent produced by Streptomyces, which reversibly binds to bacterial 50S ribosomes and inhibits protein synthesis. 

Erythromycin Ethylsuccinate Powder has antibacterial activity against Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae, Streptococcus catamorosus, Corynebacterium perfringens, Gonococcus gonorrhoeae, Campylobacter jejuni, Helicobacter pylori and Helicobacter bacillus.

Uses and functions of Erythromycin Ethylsuccinate Powder.

Erythromycin is a macrolide antibiotic, which is the ethyl succinate of erythromycin, and is more stable than erythromycin in stomach acid. This product is a bacteriostatic agent, but in high concentration, it also has bactericidal effect on some bacteria.

Erythromycin ethylsuccinate is a macrolide antibiotic, which is the ethyl succinate of erythromycin and is more stable than erythromycin in gastric acid. It has antibacterial activity against staphylococci (except methicillin-resistant strains), streptococci and gram-positive bacilli of all groups. Neisseria, Haemophilus influenzae, B. pertussis, etc. are also sensitive to Erythromycin Ethosuximide.

Erythromycin ethylsuccinate also has antibacterial effect on various anaerobic bacteria except Clostridium perfringens and Clostridium difficile. It also has inhibitory effect on Legionella, Campylobacter fetus, some spirochetes, Mycoplasma pneumoniae, Rickettsiae and Chlamydiae.

Pharmacological Effects of Erythromycin Ethylsuccinate Powder.

Erythromycin ethylsuccinate is a macrolide antibiotic, which is the ethyl succinate of erythromycin and is more stable than erythromycin in gastric acid. It has antibacterial activity against staphylococci (except methicillin-resistant strains), streptococci and gram-positive bacilli of all groups. Neisseria, Haemophilus influenzae, B. pertussis, etc. are also sensitive to Erythromycin Ethosuximide.

Erythromycin ethylsuccinate also has antibacterial effect on various anaerobic bacteria except Clostridium perfringens and Clostridium difficile. It also has inhibitory effect on Legionella, Campylobacter fetus, some spirochetes, Mycoplasma pneumoniae, Rickettsiae and Chlamydiae.

Production method of Erythromycin Ethylsuccinate Powder.